Stay updated on Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.

Latest updates to the Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAn error page is now served for the study record, replacing detailed study information with a generic message. This makes the study record inaccessible and removes key sections such as eligibility criteria, contacts, and locations from the view.SummaryDifference18%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page now shows Revision: v3.6.4 in the footer, replacing the previous Revision: v3.6.3. This indicates a small backend/content update to the page.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, indicating a minor update to the page version.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page revision has been updated to v3.6.2, indicating a newer version of the page. This update appears to be an internal improvement or patch without altering the displayed study details.SummaryDifference0.1%

- Check73 days agoChange DetectedNew help and navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study) along with labels like Last verified and Last known status was to guide readers through the page. The old labels and the previous revision tag (Intervention / Treatment and Revision: v3.5.5) were removed and a new Revision: v3.6.0 tag is now shown.SummaryDifference1%

- Check80 days agoChange DetectedThe page revision changed from v3.5.4 to v3.5.5, indicating a new version of the page. This is a minor update to the page metadata.SummaryDifference0.1%

Stay in the know with updates to Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.